Details for New Drug Application (NDA): 020919
✉ Email this page to a colleague
The generic ingredient in GEODON is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
Summary for 020919
Tradename: | GEODON |
Applicant: | Viatris |
Ingredient: | ziprasidone mesylate |
Patents: | 0 |
Suppliers and Packaging for NDA: 020919
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919 | NDA | ROERIG | 0049-3920 | 0049-3920-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0049-3920-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0049-3920-01) |
GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919 | NDA | ROERIG | 0049-3920 | 0049-3920-83 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0049-3920-83) / 1 mL in 1 VIAL, SINGLE-DOSE (0049-3920-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAMUSCULAR | Strength | EQ 20MG BASE/VIAL | ||||
Approval Date: | Jun 21, 2002 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 020919
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription